Claire C Yang1, Kevin P Weinfurt2, Robert M Merion3, Ziya Kirkali4. 1. Department of Urology, University of Washington, Seattle, Washington. 2. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina. 3. Arbor Research Collaborative for Health and the Department of Surgery, University of Michigan, Ann Arbor, Michigan. 4. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Electronic address: ziya.kirkali@nih.gov.
Abstract
PURPOSE: To address gaps in understanding and treating lower urinary tract symptoms, the NIDDK created the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). The goals of LURN are to work collaboratively to 1) identify and explain the important subtypes of lower urinary tract symptoms; 2) improve the measurement of patient experiences of lower urinary tract symptoms; 3) disseminate novel findings to researchers, clinicians and patients; and 4) generate data, research tools and biological samples for future studies. MATERIALS AND METHODS: As a first step in understanding subtypes of lower urinary tract symptoms, LURN will focus on disorders of urinary sensation (eg urgency) and their causes. These are being examined with respect to patient experience, organism or systemic factors, genitourinary organs and tissues, and cellular/molecular factors. This is being achieved via an observational cohort study that is currently enrolling patients with lower urinary tract symptoms (target number 1,000) and that will extensively characterize patients with lower urinary tract symptoms. Future studies embedded within the observational cohort study will focus on neuroimaging and sensory testing, biomarkers and organ based factors. To advance the science of measurement of lower urinary tract symptoms, LURN is also developing and evaluating a comprehensive set of self-report questions to provide more granular assessments of lower urinary tract symptoms. RESULTS: LURN has taken its first steps by developing a framework for studying lower urinary tract symptom subtypes. CONCLUSIONS: In developing this framework, LURN is choosing an initial domain on which to focus (sensory experiences), and creating and executing protocols designed to improve measurement of self-reported symptoms and identify patient subtypes.
PURPOSE: To address gaps in understanding and treating lower urinary tract symptoms, the NIDDK created the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). The goals of LURN are to work collaboratively to 1) identify and explain the important subtypes of lower urinary tract symptoms; 2) improve the measurement of patient experiences of lower urinary tract symptoms; 3) disseminate novel findings to researchers, clinicians and patients; and 4) generate data, research tools and biological samples for future studies. MATERIALS AND METHODS: As a first step in understanding subtypes of lower urinary tract symptoms, LURN will focus on disorders of urinary sensation (eg urgency) and their causes. These are being examined with respect to patient experience, organism or systemic factors, genitourinary organs and tissues, and cellular/molecular factors. This is being achieved via an observational cohort study that is currently enrolling patients with lower urinary tract symptoms (target number 1,000) and that will extensively characterize patients with lower urinary tract symptoms. Future studies embedded within the observational cohort study will focus on neuroimaging and sensory testing, biomarkers and organ based factors. To advance the science of measurement of lower urinary tract symptoms, LURN is also developing and evaluating a comprehensive set of self-report questions to provide more granular assessments of lower urinary tract symptoms. RESULTS: LURN has taken its first steps by developing a framework for studying lower urinary tract symptom subtypes. CONCLUSIONS: In developing this framework, LURN is choosing an initial domain on which to focus (sensory experiences), and creating and executing protocols designed to improve measurement of self-reported symptoms and identify patient subtypes.
Authors: Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams Journal: Eur Urol Date: 2006-10-02 Impact factor: 20.096
Authors: Holly E Richter; Heather J Litman; Emily S Lukacz; Larry T Sirls; Leslie Rickey; Peggy Norton; Gary E Lemack; Stephen Kraus; Pamela Moalli; Mary Pat Fitzgerald; Kimberly J Dandreo; Liyuan Huang; John W Kusek Journal: Obstet Gynecol Date: 2011-04 Impact factor: 7.661
Authors: Catherine S Bradley; Ingrid E Nygaard; Michelle A Mengeling; James C Torner; Colleen K Stockdale; Brenda M Booth; Anne G Sadler Journal: Am J Obstet Gynecol Date: 2012-04-16 Impact factor: 8.661
Authors: Sharon L Tennstedt; Gretchen R Chiu; Carol L Link; Heather J Litman; John W Kusek; John B McKinlay Journal: Urology Date: 2009-10-24 Impact factor: 2.649
Authors: Claire Magnon; Simon J Hall; Juan Lin; Xiaonan Xue; Leah Gerber; Stephen J Freedland; Paul S Frenette Journal: Science Date: 2013-07-12 Impact factor: 47.728
Authors: Cindy L Amundsen; Margaret E Helmuth; Abigail R Smith; John O L DeLancey; Catherine S Bradley; Kathryn E Flynn; Kimberly S Kenton; H Henry Lai; David Cella; James W Griffith; Victor P Andreev; J Eric Jelovsek; Alice B Liu; Ziya Kirkali; Claire C Yang Journal: Neurourol Urodyn Date: 2019-11-25 Impact factor: 2.696
Authors: H Henry Lai; Margaret E Helmuth; Abigail R Smith; Jonathan B Wiseman; Brenda W Gillespie; Ziya Kirkali Journal: Urology Date: 2018-10-28 Impact factor: 2.649
Authors: Nazema Y Siddiqui; Jonathan B Wiseman; David Cella; Catherine S Bradley; H Henry Lai; Margaret E Helmuth; Abigail R Smith; James W Griffith; Cindy L Amundsen; Kimberly S Kenton; J Quentin Clemens; Karl J Kreder; Robert M Merion; Ziya Kirkali; John W Kusek; Anne P Cameron Journal: J Urol Date: 2018-05-03 Impact factor: 7.450
Authors: David Cella; Abigail R Smith; James W Griffith; Kathryn E Flynn; Catherine S Bradley; Brenda W Gillespie; Ziya Kirkali; Pooja Talaty; J Eric Jelovsek; Brian T Helfand; Kevin P Weinfurt Journal: Neurourol Urodyn Date: 2019-06-21 Impact factor: 2.696
Authors: David Cella; Abigail R Smith; James W Griffith; Ziya Kirkali; Kathryn E Flynn; Catherine S Bradley; J Eric Jelovsek; Brenda W Gillespie; Brian T Helfand; Pooja Talaty; Kevin P Weinfurt Journal: J Urol Date: 2019-07-31 Impact factor: 7.450
Authors: James W Griffith; Emily E Messersmith; Brenda W Gillespie; Jonathan B Wiseman; Kathryn E Flynn; Ziya Kirkali; John W Kusek; Tamara Bavendam; David Cella; Karl J Kreder; Jasmine J Nero; Maria E Corona; Catherine S Bradley; Kimberly S Kenton; Brian T Helfand; Robert M Merion; Kevin P Weinfurt Journal: J Urol Date: 2017-07-20 Impact factor: 7.450
Authors: Gang Liu; Victor P Andreev; Margaret E Helmuth; Claire C Yang; H Henry Lai; Abigail R Smith; Jonathan B Wiseman; Robert M Merion; Bradley A Erickson; David Cella; James W Griffith; John L Gore; John O L DeLancey; Ziya Kirkali Journal: J Urol Date: 2019-05-23 Impact factor: 7.450
Authors: Nazema Y Siddiqui; Brian T Helfand; Victor P Andreev; Joseph T Kowalski; Megan S Bradley; H Henry Lai; Mitchell B Berger; Margaret G Mueller; Jennifer A Bickhaus; Vignesh T Packiam; Dee Fenner; Brenda W Gillispie; Ziya Kirkali Journal: J Urol Date: 2019-10-09 Impact factor: 7.450
Authors: Brian T Helfand; Victor P Andreev; Nazema Y Siddiqui; Gang Liu; Bradley A Erickson; Margaret E Helmuth; Susan K Lutgendorf; H Henry Lai; Ziya Kirkali Journal: Urology Date: 2019-03-25 Impact factor: 2.649
Authors: Anne P Cameron; Christina Lewicky-Gaupp; Abigail R Smith; Brian T Helfand; John L Gore; J Quentin Clemens; Claire C Yang; Nazema Y Siddiqui; H Henry Lai; James W Griffith; Victor P Andreev; Gang Liu; Kevin Weinfurt; Cindy L Amundsen; Catherine S Bradley; John W Kusek; Ziya Kirkali Journal: J Urol Date: 2017-10-28 Impact factor: 7.450